TAYLOR BEN R (Chief Financial Officer) received a stock award from RECURSION PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
Class A Common Stock
Shares
+370.34K
Price / share
—
Trade value
—
% of position
Net shares
+370.34K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 12/19/2024 | A · Award | +370.34K | — | — | 78.2% | 473.87K | 844.21K |
| Total | +370.34K | $0.00 | ||||||
Stock Option (Right to Buy)
Class A Common Stock
740.69K shares
Shares
+740.69K
Strike price
6.09
Held after
740.69K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock740.69K shares | 12/19/2024 | A · Award | +740.69K | 6.09 | — | 740.69K |
Stock Option (Right to Buy)
DirectUnderlying shares
0.00
Shares owned
81.15K
Exercise price
0.14
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
0.00
Shares owned
92.75K
Exercise price
0.06
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
0.00
Shares owned
289.84K
Exercise price
0.04
Expiration
—
Exercise window
—
Underlying
0.00
Owned
463.74K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock | 0.14 | — | — | 0.00 | 81.15K |
| Stock Option (Right to Buy) Direct | Class A Common Stock | 0.06 | — | — | 0.00 | 92.75K |
| Stock Option (Right to Buy) Direct | Class A Common Stock | 0.04 | — | — | 0.00 | 289.84K |
| Total | 0.00 | 463.74K | ||||